Abu-Rustum NR, Yashar CM, Bradley K, Campos SM, Chino J, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, et al: NCCN Guidelines® Insights: Uterine NeoplasmsVersion 3.2021. Journal of the National Comprehensive Cancer Network: JNCCN 2021, (8):888–895.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Cancer J Clin. 2021;71(3):209–49.
Article
Google Scholar
Lim MC, Won YJ, Ko MJ, Kim M, Shim SH, Suh DH, Kim JW. Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015. Journal of gynecologic oncology 2019, 30(1):e38.
Legge F, Restaino S, Leone L, Carone V, Ronsini C, Di Fiore GLM, Pasciuto T, Pelligra S, Ciccarone F, Scambia G, et al. Clinical outcome of recurrent endometrial cancer: analysis of post-relapse survival by pattern of recurrence and secondary treatment. Int J Gynecol cancer: official J Int Gynecol Cancer Soc. 2020;30(2):193–200.
Article
Google Scholar
de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, D’Amico R, et al. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial. Lancet Oncol. 2019;20(9):1273–85.
Article
PubMed
PubMed Central
Google Scholar
Matei D, Filiaci V, Randall ME, Mutch D, Steinhoff MM, DiSilvestro PA, Moxley KM, Kim YM, Powell MA, O’Malley DM, et al: Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer. 2019, 380(24):2317–2326.
Randall ME, Filiaci V, McMeekin DS, von Gruenigen V, Huang H, Yashar CM, Mannel RS, Kim JW, Salani R, DiSilvestro PA, et al. Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer. J Clin oncology: official J Am Soc Clin Oncol. 2019;37(21):1810–8.
Article
CAS
Google Scholar
Scott SA, van der Zanden C, Cai E, McGahan CE, Kwon JS. Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer. Gynecol Oncol. 2017;145(2):262–8.
Article
PubMed
CAS
Google Scholar
Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, Marth C, Nout R, Querleu D, Mirza MR, et al: ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. (1569–8041 (Electronic)).
Hosmer DWaL S. Applied Logistic Regression. New York: John Wiley & Sons, Inc.; 1989.
Google Scholar
Lee TS, Jung JY, Kim JW, Park NH, Song YS, Kang SB, Lee HP. Feasibility of ovarian preservation in patients with early stage endometrial carcinoma. Gynecol Oncol. 2007;104(1):52–7.
Article
PubMed
Google Scholar
Wright JD, Buck AM, Shah M, Burke WM, Schiff PB, Herzog TJ. Safety of ovarian preservation in premenopausal women with endometrial cancer. J Clin oncology: official J Am Soc Clin Oncol. 2009;27(8):1214–9.
Article
Google Scholar
Shin W, Park SY, Kang S, Lim MC, Seo SS. The survival effect of ovary preservation in early stage endometrial cancer: a single institution retrospective analysis. J ovarian Res. 2020;13(1):97.
Article
PubMed
PubMed Central
CAS
Google Scholar
Park JY, Nam JH. Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer. Oncologist. 2015;20(3):270–8.
Article
PubMed
PubMed Central
CAS
Google Scholar
Park JY, Kim DY, Kim TJ, Kim JW, Kim JH, Kim YM, Kim YT, Bae DS, Nam JH. Hormonal therapy for women with stage IA endometrial cancer of all grades. Obstet Gynecol. 2013;122(1):7–14.
Article
PubMed
CAS
Google Scholar
Kim MK, Seong SJ, Kang SB, Bae DS, Kim JW, Nam JH, Lim MC, Lee TS, Kim S, Paek J. Six months response rate of combined oral medroxyprogesterone/levonorgestrel-intrauterine system for early-stage endometrial cancer in young women: a Korean Gynecologic-Oncology Group Study. J gynecologic Oncol. 2019;30(2):e47.
Article
CAS
Google Scholar
Laurelli G, Falcone F, Gallo MS, Scala F, Losito S, Granata V, Cascella M, Greggi S. Long-Term Oncologic and Reproductive Outcomes in Young Women With Early Endometrial Cancer Conservatively Treated: A Prospective Study and Literature Update. Int J Gynecol cancer: official J Int Gynecol Cancer Soc. 2016;26(9):1650–7.
Article
Google Scholar
Falcone F, Leone Roberti Maggiore U, Di Donato V, Perrone AM, Frigerio L, Bifulco G, Polterauer S, Casadio P, Cormio G, Masciullo V, et al. Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study. J gynecologic Oncol. 2020;31(5):e74.
Article
Google Scholar
Falcone F, Laurelli G, Losito S, Di Napoli M, Granata V, Greggi S. Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer. J gynecologic Oncol. 2017;28(1):e2.
Article
Google Scholar
Murali R, Soslow RA, Weigelt B. Classification of endometrial carcinoma: more than two types. Lancet Oncol. 2014;15(7):e268–78.
Article
PubMed
Google Scholar
Yen T-T, Wang T-L, Fader AN, Shih I-M, Gaillard S. Molecular Classification and Emerging Targeted Therapy in Endometrial Cancer. Int J Gynecol Pathol. 2020;39(1):26–35.
Article
PubMed
PubMed Central
CAS
Google Scholar
Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet (London England). 2010;375(9721):1165–72.
Article
Google Scholar
Talhouk A, McAlpine JN. New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care. Gynecol Oncol Res Pract. 2016;3:14–4.
Article
PubMed
PubMed Central
CAS
Google Scholar
Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373–9.
Article
PubMed
CAS
Google Scholar
Yura Y, Tauchi K, Koshiyama M, Konishi I, Yura S, Mori T, Matsushita K, Hayashi M, Yoshida M. Parametrial involvement in endometrial carcinomas: its incidence and correlation with other histological parameters. Gynecol Oncol. 1996;63(1):114–9.
Article
PubMed
CAS
Google Scholar
Nwachukwu C, Baskovic M, Von Eyben R, Fujimoto D, Giaretta S, English D, Kidd E. Recurrence risk factors in stage IA grade 1 endometrial cancer. J gynecologic Oncol. 2021;32(2):e22.
Article
Google Scholar
Veade AE, Foote J, Ehrisman J, Broadwater G, Davidson BA, Lee PS, Secord AA, Berchuck A, Havrilesky LJ. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma. World J Surg Oncol. 2019;17(1):80.
Article
PubMed
PubMed Central
Google Scholar
Larson DM, Connor GP, Broste SK, Krawisz BR, Johnson KK. Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol. 1996;88(3):394–8.
Article
PubMed
CAS
Google Scholar
Geels YP, Pijnenborg JMA, van den Berg-van Erp SHM, Snijders MPML, Bulten J, Massuger LFAG. Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%. Gynecol Oncol. 2013;129(2):285–91.
Article
PubMed
CAS
Google Scholar